Evidence map›Paper›PMID 39710778›Full record

ArticleSignal transduction and targeted therapy2024

Advancing type 1 diabetes therapy: autologous islet transplant breakthrough.

Ram Abou Zaki, Assam El-Osta

Registry-linked trialAbstract read
In one paragraph

Article in Signal transduction and targeted therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06951074 (Autologous Insulin Producing Mesenchymal Stem Cell Transplantation in Youth With Type 1 Diabetes), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06951074 phase2 / phase3recruitingnot on this mapstarted 2025, after this paper: background citation

Autologous Insulin Producing Mesenchymal Stem Cell Transplantation in Youth With Type 1 Diabetes

TypeinterventionalSponsorAin Shams UniversityRan2025 to 2026Enrolled20ConditionsStem Cells, Type 1 DiabetesArmsInsulin producing stem cells infusion
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ram Abou ZakiBaker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, VIC, Australia.
Assam El-OstaBaker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, VIC, Australia. sam.el-osta@baker.edu.au.

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 1154650Department of Health | National Health and Medical Research Council (NHMRC) APP2014763JDRF 2-SRA-2024-1442-S-BNovo Nordisk Fonden (Novo Nordisk Foundation) NNF17SA0031406
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39710778
PMCPMC11663981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.